Abstract:Rcn1/RCAN1, also known as Down syndrome critical region gene 1 (DSCR1), is a highly conserved intrinsic inhibitor of calcineurin. Our study revealed that overexpression of Rcn1 diminishes arsenite tolerance independently of calcineurin regulation in fission yeast. Notably, calcineurin knockout (Δppb1) cells exhibited arsenite tolerance in an Rcn1‐dependent manner. These findings unveil a previously unrecognized functional collaboration between Rcn1 and calcineurin. Calcineurin (CN) is a conserved Ca2+/calmodulin‐dependent phosphoprotein phosphatase that plays a key role in Ca2+ signaling. Regulator of calcineurin 1 (RCAN1), also known as Down syndrome critical region gene 1 (DSCR1), interacts with calcineurin and inhibits calcineurin‐dependent signaling in various organisms. Ppb1, the fission yeast calcineurin regulates Cl−‐homeostasis, and Ppb1 deletion induces MgCl2 hypersensitivity. Here, we characterize the conserved and novel roles of the fission yeast RCAN1 homolog rcn1+. Consistent with its role as an endogenous calcineurin inhibitor, Rcn1 overproduction reproduced the calcineurin‐null phenotypes, including MgCl2 hypersensitivity and inhibition of calcineurin signaling upon extracellular Ca2+ stimuli as evaluated by the nuclear translocation and transcriptional activation of the calcineurin substrate Prz1. Notably, overexpression of rcn1+ causes hypersensitivity to arsenite, whereas calcineurin deletion induces arsenite tolerance, showing a phenotypic discrepancy between Rcn1 overexpression and calcineurin deletion. Importantly, although Rcn1 deletion induces modest sensitivities to arsenite and MgCl2 in wild‐type cells, the arsenite tolerance, but not MgCl2 sensitivity, associated with Ppb1 deletion was markedly suppressed by Rcn1 deletion. Collectively, our findings reveal a previously unrecognized functional collaboration between Rcn1 and calcineurin, wherein Rcn1 not only negatively regulates calcineurin in the Cl− homeostasis, but also Rcn1 mediates calcineurin signaling to modulate arsenite cytotoxicity.

Enzymatic and thermodynamic analysis of calcineurin inhibition by RCAN1

Biochemical analyses reveal new insights into RCAN1/Rcn1 inhibition of calcineurin

The RCAN1.4-calcineurin/NFAT Signaling Pathway is Essential for Hypoxic Adaption of Intervertebral Discs

Cooperative autoinhibition and multi-level activation mechanisms of calcineurin

Modulation of Calcineurin Activity in Mouse Brain by Chronic Oral Administration of Cyclosporine A.

The Regulatory Domains of Cna Have Different Effects on the Inhibition of Cn Activity by Fk506 and Csa

A New Family of Regulators of Calcineurin (Rcans)

RCAN1-mediated Calcineurin Inhibition As a Target for Cancer Therapy

The effect of RCAN1 on cancer

P38α MAP Kinase Phosphorylates RCAN1 and Regulates Its Interaction with Calcineurin

Effect of Different Immunosuppressive Drugs on Calcineurin and Its Mutants

Regulator of Calcineurin 1 Gene Transcription is Regulated by Nuclear Factor-Kappab

Effects of cyclosporin A, FK506 and rapamycin on calcineurin phosphatase activity in mouse brain.

Quercetin Targets the Interaction of Calcineurin with LxVP-type Motifs in Immunosuppression.

Inhibition of Calcineurin by Quercetin in Vitro and in Jurkat Cells.

Regulators of Calcineurin 1 Deficiency Attenuates Tubulointerstitial Fibrosis Through Improving Mitochondrial Fitness.

The regulator of calcineurin 1 (RCAN1) inhibits nuclear factor kappaB signaling pathway and suppresses human malignant glioma cells growth.

RCAN1.4 Attenuates Renal Fibrosis Through Inhibiting Calcineurin-Mediated Nuclear Translocation of NFAT2

Rcn1, the fission yeast homolog of human DSCR1, regulates arsenite tolerance independently from calcineurin

The Secondary Structure of Calcineurin Regulatory Region and Conformational Change Induced by Calcium/Calmodulin Binding*

Usp16-Mediated Deubiquitination Of Calcineurin A Controls Peripheral T Cell Maintenance